Zobrazeno 1 - 10
of 23
pro vyhledávání: '"E Molina-Cuadrado"'
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 4, Pp 266-275 (2014)
Objective: To assess the cost-effectiveness relationship of Ticagrelor versus Clopidogrel for the management of acute coronary syndrome in Spain. Methods: The data from the PLATO study were used for the calculation of the events rate and health-relat
Externí odkaz:
https://doaj.org/article/7061dd06320b485eb26dc04d4a15e325
Publikováno v:
Eur J Hosp Pharm
Background Atypical haemolytic uraemic syndrome (aHUS) is a thrombotic microangiopathy that primarily affects the kidney. Purpose To compare the effectiveness and cost of eculizumab (monoclonal antibody indicated for the treatment of aHUS) on a patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6fdffa839bcb6baf88b42385450f95
https://europepmc.org/articles/PMC7535341/
https://europepmc.org/articles/PMC7535341/
Publikováno v:
Production and preparation.
Background Decitabine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) de novo or secondary, according to the classification of the WHO, who are not candidates for conventional induction chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5de4fba705492b1e7daff416343b03b
https://doi.org/10.1136/ejhpharm-2017-000640.456
https://doi.org/10.1136/ejhpharm-2017-000640.456
Publikováno v:
Clinical pharmacy.
Background Acute myeloid leukaemia (AML) is the most frequent adult leukaemia. Hypomethylating agents such as azacitidine or decitabine are indicated for patients not eligible to receive intensive treatment (patients >65 years of age, which represent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be99892c36d8b4b5ce86833216b95dee
https://doi.org/10.1136/ejhpharm-2017-000640.136
https://doi.org/10.1136/ejhpharm-2017-000640.136
Publikováno v:
Clinical pharmacy.
Background Retinopathy of prematurity (ROP) is a proliferative disease of the retinal vasculature that can cause severe visual loss in premature newborns. Intravitreal bevacizumab has shown promise as a treatment for ROP. Purpose To evaluate the effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65deb22f82e8dd04a99364495c1c4b4f
https://doi.org/10.1136/ejhpharm-2017-000640.22
https://doi.org/10.1136/ejhpharm-2017-000640.22
Publikováno v:
Drug information and pharmacotherapy.
Background Dimethyl fumarate (DMF) represents a new class of treatment for patients with relapsing remitting multiple sclerosis (RRMS). Scientific investigations are still in progress to clarify the ultimate mechanism of action responsible for the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::526ad42583663a9afa7abb6e540969c6
https://doi.org/10.1136/ejhpharm-2017-000640.262
https://doi.org/10.1136/ejhpharm-2017-000640.262
Publikováno v:
Drug information and pharmacotherapy.
Background Toxic epidermal necrolysis (TEN) is a rare immune mediated life threatening reaction for which drugs account for more than 95% of cases. The incidence of TEN is 0.4–1.2 cases per million population per year. TEN are more commonly caused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::108ba34808ead744ba52edcfd98786da
https://doi.org/10.1136/ejhpharm-2017-000640.267
https://doi.org/10.1136/ejhpharm-2017-000640.267
Publikováno v:
European Journal of Hospital Pharmacy. 23:A125.1-A125
Background Natalizumab increases the risk of progressive multifocal leukoencephalopathy (PML), a potentially lethal brain disorder caused by JC polyomavirus (JCV). The antimalarial mefloquine has shown activity against JCV in vitro , but little evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be94b661d40c12f298367d51418681e6
https://doi.org/10.1136/ejhpharm-2016-000875.284
https://doi.org/10.1136/ejhpharm-2016-000875.284
Autor:
F Verdejo Reche, H Mateo Carrasco, P Nieto Guindo, E Molina Cuadrado, D Fernández Ginés, A Alonso Martin
Publikováno v:
European Journal of Hospital Pharmacy. 22:A141.1-A141
Background Medicines reconciliation is known to minimise medicines errors and reduce morbidity in hospitalised patients. Its role in the Intensive Care Unit (ICU) has not been widely studied. Purpose To analyse the number, type, and importance of pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56cb2c0c613fdcc0c6b97846bccca368
https://doi.org/10.1136/ejhpharm-2015-000639.339
https://doi.org/10.1136/ejhpharm-2015-000639.339
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.